{
  "articles": [
    {
      "path": "about.html",
      "title": "about this site",
      "description": "for researchers' internal use",
      "author": [],
      "contents": "\n\n\n\n",
      "last_modified": "2021-04-30T18:04:03+01:00"
    },
    {
      "path": "data.html",
      "title": "Encoding the models",
      "description": "Need to ensure indexing in data is same in software, math is the bridge.\n",
      "author": [],
      "date": "`r Sys.Date()`",
      "contents": "\n\nContents\ngeneral structure of the data for the model\nraw data\nstudy-level identifier\ntreatments\nmeasures\ntimepoints\nscales\n\n\n\n\n\n\n\ngeneral structure of the data for the model\nWe need to have rows as arm-based observations per study, with columns that identify the statistics, the study, the treatment, and any moderators or subgroups.\nraw data\nCurrent raw data loaded into the analysis:\n\n[1] \"adverse-events.csv\"                                \n[2] \"Mood.csv\"                                          \n[3] \"Pain intensity.csv\"                                \n[4] \"review_91309_extracted_data_csv_20210420002814.csv\"\n\nAside from the covidence extracted_data, these files comprise row-identifiers (Study Identifier, Comments, and Intervention), along with outcome-relevant columns identified by Hollie.\n\n\n# confirm this assumption\n\n# count the number of unique combinations of \n# study, title, and intervention in rows\nn_obs <- \nmetapar_consult %>% \n  select(study, study_title, arm) %>% \n  distinct() %>% \n  nrow()\n\n# check this number is the same as the number of rows\n# i.e., we can uniquely identify the rows with the values in these three columns\nnrow(metapar_consult) == n_obs\n\n\n[1] TRUE\n\nstudy-level identifier\nWe need columns or dataframes to encode all of the indexes. Using (White et al. 2019)’s nomenclature, we have \\(i = 1, \\dots, n\\) studies.\nSince there are sometimes more than one title per study, we’ll tag studies with :n.\n\nhtml {\n  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;\n}\n\n#koexwdlrlv .gt_table {\n  display: table;\n  border-collapse: collapse;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 16px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#koexwdlrlv .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 0;\n  padding-bottom: 4px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#koexwdlrlv .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_col_heading {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#koexwdlrlv .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#koexwdlrlv .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#koexwdlrlv .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#koexwdlrlv .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#koexwdlrlv .gt_group_heading {\n  padding: 8px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#koexwdlrlv .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#koexwdlrlv .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#koexwdlrlv .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#koexwdlrlv .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#koexwdlrlv .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 12px;\n}\n\n#koexwdlrlv .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#koexwdlrlv .gt_first_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#koexwdlrlv .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#koexwdlrlv .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding: 4px;\n}\n\n#koexwdlrlv .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#koexwdlrlv .gt_sourcenote {\n  font-size: 90%;\n  padding: 4px;\n}\n\n#koexwdlrlv .gt_left {\n  text-align: left;\n}\n\n#koexwdlrlv .gt_center {\n  text-align: center;\n}\n\n#koexwdlrlv .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#koexwdlrlv .gt_font_normal {\n  font-weight: normal;\n}\n\n#koexwdlrlv .gt_font_bold {\n  font-weight: bold;\n}\n\n#koexwdlrlv .gt_font_italic {\n  font-style: italic;\n}\n\n#koexwdlrlv .gt_super {\n  font-size: 65%;\n}\n\n#koexwdlrlv .gt_footnote_marks {\n  font-style: italic;\n  font-size: 65%;\n}\nstudy\n      study_title\n    foster 2010 : 1\n      oral desipramine and topical lid...\n    foster 2010 : 2\n      effect of amitriptyline on sympt...\n    arnold 2012 : 1\n      efficacy and safety of duloxetin...\n    arnold 2012 : 2\n      safety and efficacy of esreboxet...\n    arnold 2010 : 1\n      efficacy and safety of milnacipr...\n    arnold 2010 : 2\n      flexible dosed duloxetine in the...\n    \n\ntreatments\nWe also have \\(k = 1, \\dots, K\\) treatments. But what will constitute a treatment will be different depending on the model.\nBest to separate drug name from dosage.\nWe will use Intervention Name\n\n# A tibble: 6 x 2\n  name              n\n  <chr>         <int>\n1 <NA>            104\n2 duloxetine       52\n3 amitriptyline    48\n4 placebo          36\n5 milnacipran      20\n6 fluoxetine       15\n\nFirst we check that the NA values are all placebo.\n\n\nmetapar_consult %>% \n  filter(is.na(name)) %>% \n  count(type) %>% \n  arrange(desc(n))\n\n\n# A tibble: 17 x 2\n   type                                n\n   <chr>                           <int>\n 1 placebo                            85\n 2 active placebo                      3\n 3 anticonvulsant                      2\n 4 active comparator                   1\n 5 antidepressant                      1\n 6 cardiovascular fitness training     1\n 7 epidural injection + placebo        1\n 8 neurofeedback                       1\n 9 opioid                              1\n10 painkiller                          1\n11 placebo + anticonvulsant            1\n12 placebo + ibuprofen 1800mg          1\n13 placeco                             1\n14 psychological therapy               1\n15 skeletal muscle relaxant            1\n16 synthetic cannabinoid               1\n17 usual care                          1\n\nThere is one antidepressant without a name.\n\n\n# get to that specific obs\nmetapar_consult %>% \n  filter(\n    is.na(name), \n    type == \"antidepressant\") %>% \n   select(study, study_title, arm, class)\n\n\n# A tibble: 1 x 4\n  study     study_title                             arm          class\n  <glue>    <chr>                                   <chr>        <chr>\n1 tasmuth … venlafaxine in neuropathic pain follow… venlafaxine… snri \n\nmeasures\nWe pivot longer and wider to get observations.\n\n[[1]]\n# A tibble: 232 x 5\n   outcome study_arm                   measure_desc      percent n    \n   <chr>   <chr>                       <chr>             <chr>   <chr>\n 1 adverse Lee 2010 = Placebo          adverse_events_e… 12      <NA> \n 2 adverse Lee 2010 = Venlafaxine - 7… adverse_events_e… 52      <NA> \n 3 adverse Keskinbora 2006 = Gabapent… adverse_events_e… 23.1    6    \n 4 adverse Keskinbora 2006 = Amitript… adverse_events_e… 69.2    18   \n 5 adverse Cannon 1994 = Placebo       adverse_events_e… 55      11   \n 6 adverse Cannon 1994 = Clonidine     adverse_events_e… 70      14   \n 7 adverse Cannon 1994 = Imipramine 5… adverse_events_e… 75      15   \n 8 adverse Riesner 2008 = Placebo      adverse_events_e… 70      21   \n 9 adverse Riesner 2008 = Fluvoxamine… adverse_events_e… 93.3    28   \n10 adverse Watson 1998 = Amitriptylin… adverse_events_e… 93.9    31   \n# … with 222 more rows\n\n[[2]]\n# A tibble: 1,798 x 13\n   outcome study_arm measure_desc n     mean  sd    median range se   \n   <chr>   <chr>     <chr>        <chr> <chr> <chr> <chr>  <chr> <chr>\n 1 pain    Lee 2010… pain_chest_… 21    <NA>  <NA>  <NA>   <NA>  <NA> \n 2 pain    Lee 2010… pain_chest_… 21    78.2  16.2  <NA>   <NA>  <NA> \n 3 pain    Lee 2010… sf_36_body_… 21    51.9  14.3  <NA>   <NA>  <NA> \n 4 pain    Lee 2010… sf_36_body_… 21    52.4  14.3  <NA>   <NA>  <NA> \n 5 pain    Lee 2010… pain_chest_… 22    <NA>  <NA>  <NA>   <NA>  <NA> \n 6 pain    Lee 2010… pain_chest_… 22    36.5  20.7  <NA>   <NA>  <NA> \n 7 pain    Lee 2010… sf_36_body_… 22    51.4  12.9  <NA>   <NA>  <NA> \n 8 pain    Lee 2010… sf_36_body_… 22    52.7  13    <NA>   <NA>  <NA> \n 9 pain    dsrhv 20… pain_vas_0_… 21    7.62  0.86  <NA>   <NA>  <NA> \n10 pain    dsrhv 20… pain_vas_0_… 21    7.48  1.29  <NA>   <NA>  <NA> \n# … with 1,788 more rows, and 4 more variables: iqr <chr>,\n#   percent <chr>, ci <chr>, intervals <chr>\n\n[[3]]\n# A tibble: 1,268 x 12\n   outcome study_arm   measure_desc    mean  n     sd    percent se   \n   <chr>   <chr>       <chr>           <chr> <chr> <chr> <chr>   <chr>\n 1 mood    Lee 2010 =… depression_bec… 9.92  21    0.69  <NA>    <NA> \n 2 mood    Lee 2010 =… depression_bec… <NA>  21    <NA>  <NA>    <NA> \n 3 mood    Lee 2010 =… sf_36_mental_h… 49.1  21    13.6  <NA>    <NA> \n 4 mood    Lee 2010 =… sf_36_mental_h… 50.3  21    14.2  <NA>    <NA> \n 5 mood    Lee 2010 =… depression_bec… 9.72  22    0.69  <NA>    <NA> \n 6 mood    Lee 2010 =… depression_bec… <NA>  22    <NA>  <NA>    <NA> \n 7 mood    Lee 2010 =… sf_36_mental_h… 52.9  22    19.5  <NA>    <NA> \n 8 mood    Lee 2010 =… sf_36_mental_h… 55.1  22    19.6  <NA>    <NA> \n 9 mood    dsrhv 2018… depression_bdi… <NA>  5     <NA>  23.8    <NA> \n10 mood    dsrhv 2018… depression_bdi… <NA>  9     <NA>  42.9    <NA> \n# … with 1,258 more rows, and 4 more variables: range <chr>,\n#   median <chr>, ci <chr>, intervals <chr>\n\ntimepoints\nscales\nThere are lots of scales, so Hollie created this fab measure identification dataset.\n\n\n\nWhite, Ian R., Rebecca M. Turner, Amalia Karahalios, and Georgia Salanti. 2019. “A Comparison of Arm-Based and Contrast-Based Models for Network Meta-Analysis.” Statistics in Medicine 38 (27): 5197–5213. https://doi.org/https://doi.org/10.1002/sim.8360.\n\n\n———. 2019. “A Comparison of Arm-Based and Contrast-Based Models for Network Meta-Analysis.” Statistics in Medicine 38 (27): 5197–5213. https://doi.org/https://doi.org/10.1002/sim.8360.\n\n\n———. 2019. “A Comparison of Arm-Based and Contrast-Based Models for Network Meta-Analysis.” Statistics in Medicine 38 (27): 5197–5213. https://doi.org/https://doi.org/10.1002/sim.8360.\n\n\n———. 2019. “A Comparison of Arm-Based and Contrast-Based Models for Network Meta-Analysis.” Statistics in Medicine 38 (27): 5197–5213. https://doi.org/https://doi.org/10.1002/sim.8360.\n\n\n———. 2019. “A Comparison of Arm-Based and Contrast-Based Models for Network Meta-Analysis.” Statistics in Medicine 38 (27): 5197–5213. https://doi.org/https://doi.org/10.1002/sim.8360.\n\n\n———. 2019. “A Comparison of Arm-Based and Contrast-Based Models for Network Meta-Analysis.” Statistics in Medicine 38 (27): 5197–5213. https://doi.org/https://doi.org/10.1002/sim.8360.\n\n\n\n\n",
      "last_modified": "2021-04-30T20:09:47+01:00"
    },
    {
      "path": "index.html",
      "title": "hpp",
      "description": "Welcome to the website. I hope you enjoy it!\n",
      "author": [],
      "contents": "\n\n\n\n",
      "last_modified": "2021-04-30T18:04:03+01:00"
    }
  ],
  "collections": []
}
